The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Acceleron Pharma Inc. COM 00434H108 11,830 278,753 SH   SOLE   278,753 0 0
Achaogen, Inc. COM 004449104 25,508 2,375,000 SH   SOLE   2,375,000 0 0
Aclaris Therapeutics, Inc. COM 00461U105 5,251 212,950 SH   SOLE   212,950 0 0
Aerie Pharmaceuticals, Inc. COM 00771V108 116,541 1,950,477 SH   SOLE   1,950,477 0 0
Aimmune Therapeutics, Inc. COM 00900T107 28,926 764,824 SH   SOLE   764,824 0 0
Alder BioPharmaceuticals, Inc. COM 014339105 32,600 2,847,130 SH   SOLE   2,847,130 0 0
Ascendis Pharma A/S SPONSORED ADR 04351P101 13,471 336,264 SH   SOLE   336,264 0 0
Biohaven Pharmaceutical Holding Company Ltd. COM G11196105 2,852 105,706 SH   SOLE   105,706 0 0
Blueprint Medicines Corporation COM 09627Y109 30,164 400,000 SH   SOLE   400,000 0 0
CymaBay Therapeutics, Inc. COM 23257D103 5,520 600,000 SH   SOLE   600,000 0 0
Epizyme, Inc. COM 29428V104 12,528 998,278 SH   SOLE   998,278 0 0
Immunomedics, Inc. COM 452907108 43,632 2,700,000 SH   SOLE   2,700,000 0 0
Myokardia, Inc. COM 62857M105 12,848 305,187 SH   SOLE   305,187 0 0
Pacific Biosciences of California, Inc. COM 69404D108 1,181 447,520 SH   SOLE   447,520 0 0
Tocagen, Inc. COM 888846102 1,523 148,552 SH   SOLE   148,552 0 0
Verona Pharma Plc SPONSORED ADS 925050106 6,273 528,422 SH   SOLE   528,422 0 0
WAVE Life Sciences Ltd. SHS Y95308105 5,698 162,347 SH   SOLE   162,347 0 0